Document:

EXHIBIT 10.2

                             SUBSCRIPTION AGREEMENT

M.E.R.Corporation
2400, 10303 Jasper Ave.,
Edmonton, Alberta
T5J 3T8

Attn: Ronald Mercier

     1.  APPLICATION.  The  undersigned  ("Investor"),  intending  to be legally
bound, hereby subscribes for ______________ Shares of the $.001 par value Common
Stock  ("Securities") of M.E.R.,  Inc, a Nevada corporation (the "Company") at a
purchase  price  of ten  cents($0.10)  per  Share,  equaling  a total  price  of
_______________________________ Dollars ($____________).

     The  undersigned   understands   that  his/her   Subscription  to  purchase
Securities may be accepted or rejected in whole or in part by the Company in its
sole  discretion.   Enclosed  is  the   undersigned's   check  made  payable  to
Manufacturers  and Traders Trust  Company/M.E.R.Corporation  Escrow Account" and
has been forwarded to the escrow account in the self-addressed  stamped envelope
that has been  provided for  convenience.  The Investor may also elect to submit
his  subscription  funds to the escrow  account VIA wire transfer as provided in
this Agreement.

     2. REPRESENTATIONS AND WARRANTIES.  The undersigned represents and warrants
as follows:

(a)  The Securities are being purchased  solely for the  undersigned's  account,
     for  investment  purposes only and not with a view to the  distribution  of
     said Securities and not with a view to assignment or resale thereof, and no
     other  person  will have a direct or indirect  beneficial  interest in such
     Securities.

(b)  The undersigned,  if a corporation,  partnership,  trust or other entity is
     authorized and otherwise duly qualified to purchase and hold the Securities
     and to enter into this Subscription Agreement.

     3. MISCELLANEOUS.

(a)  This  Subscription  Agreement  shall survive the death or disability of the
     undersigned and shall be binding upon the undersigned's  heirs,  executors,
     administrators, successors and permitted assigns.

(b)  This Subscription Agreement has been duly and validly authorized,  executed
     and delivered by the undersigned  and  constitutes  the valid,  binding and
     enforceable agreement of the undersigned. If this Subscription Agreement is
     being completed on behalf of a corporation,  partnership,  or trust, it has
     been  completed and executed by an authorized  corporate  officer,  general
     partner, or trustee.

                                       1
<PAGE>
(c)  This  Subscription  Agreement  referred  to herein  constitutes  the entire
     agreement  between the parties  hereto with  respect to the subject  matter
     hereof and together supersede all prior discussions or agreements  relating
     to the purchase of these Securities.

(d)  Within five (5) days after  receipt of a written  request from the Company,
     the undersigned agrees to provide such information,  to execute and deliver
     such documents and to take, or forbear from taking, such actions or provide
     such  further  assurances  as  reasonably  may be  necessary to correct any
     errors in  documentation  or to  comply  with any and all laws to which the
     Company is subject.

(e)  The  Company  shall be  notified  immediately  of any  change in any of the
     information  contained above occurring prior to the undersigned's  purchase
     of the Securities or at any time  thereafter for so long as the undersigned
     is a holder of the Securities.

     4.  REPRESENTATIONS.  The undersigned  hereby  additionally  represents and
warrants that:

     (I) The  undersigned is purchasing for  his/her/its  own account and not on
     behalf of any other person.

     (II) The  undersigned  will not sell or  assign  the  Securities  except in
     accordance  with the  provisions of the Securities Act of 1933, as amended,
     or pursuant to the registration  Requirements under the Act, or pursuant to
     an available  exemption  under the Act such as Rule 144,  which  requires a
     prior holding period of not less than one year from date of purchase.

     (III) Share certificates shall bear an appropriate  restrictive legend that
     restricts  the  further  sale or  assignment  of the  Securities  except in
     accordance with the foregoing provisions set forth above.

     (IV) The  undersigned  is aware  that  there is no  public  market  for the
     Company's  Securities that the transfer of Securities is subject to certain
     restrictions  according to law and that,  as a  consequence,  it may not be
     possible for the undersigned to liquidate the Securities, which may have to
     be held indefinitely, which makes this offering an illiquid investment.

     5. ACCREDITED  INVESTOR  CERTIFICATION.  The undersigned further represents
and warrants as indicated below:

     (Please mark one or more of the seven following statements)

[ ]  1. I am a natural person who had individual  income of more than $200,000
        in each of the most recent two years,  or joint income with my spouse in
        excess of $300,000 in each of the most recent two years,  and reasonably
        expect to reach that same income  level for the current  year.  The term

                                       2
<PAGE>
        "income", for purposes of this Subscription Agreement, shall be computed
        as follows:  individual  adjusted  gross  income,  as reported (or to be
        reported) on a federal income tax return, increased by (1) any deduction
        of long-term  capital gains under  Section 1202 of the current  Internal
        Revenue Code (the "Code"), (2) any deduction for depletion under Section
        611 of the Code, (3) any exclusion for interest under Section 103 of the
        Codes and (4) any losses of a  partnership  as reported on Schedule E of
        Form 1040);

[ ]  2. I am a natural person whose individual net worth (i.e.,  total assets in
        excess of total liabilities), or joint net worth with my spouse, will at
        the time of purchase of the Securities be in excess of $1,000,000;

[ ]  3. The  Investor  is a trust,  which  trust has  total  assets in excess of
        $5,000,000,  which is not formed for the  specific  purpose of acquiring
        the  Securities  being  offered  and whose  purchase  is  directed  by a
        sophisticated person as described in Rule 506(b)(ii) of Regulation D and
        who has such knowledge and experience in financial and business  matters
        that he is capable of  evaluating  the risks and merits of an investment
        in the Securities;

[ ]  4. The  Investor is an employee  benefit plan within the meaning of Title I
        of the Employee  Retirement  Income Security Act of 1974, and either (a)
        the investment decision will be made by a plan fiduciary,  as defined in
        Section 3 (21) of such Act, which is either a bank,  insurance  company,
        or a registered investment adviser; or (b) the employee benefit plan has
        total assets in excess of $5,000,000;  or (c) the employee  benefit plan
        is a self-directed  plan, within the meaning of Title I of such act, and
        the person directing the purchase is an Accredited Investor. *

[ ]  5. The Investor otherwise  satisfies the requirements of Section 501(a)(1),
        or satisfying the requirements of Section 501(a)(2) or (3) of Regulation
        D  promulgated  under the Act,  which  includes but is not limited to, a
        self-directed  employee benefit plan where investment decisions are made
        solely by persons who are "Accredited Investors" as otherwise defined in
        Regulation D;

[ ]  6. I am a Director or Executive Officer of the Company; or

[ ]  7. The  Investor  is an  entity  (other  than a trust)  in which all of the
        equity  owners  meet  the  requirements  of at  least  one of the  above
        subparagraphs.

     The undersigned has executed this  Subscription  Agreement this _______ day
of ___________________________, 2004.

_________________________ x $per share = $_________________ USD
(Shares being purchased)                  (Subscription Price)

                                       3
<PAGE>
If the Investor is an individual,  check whether purchased as [ ] JOINT TENANTS,
as [ ] TENANTS IN COMMON, as [ ] COMMUNITY PROPERTY, or as an [ ] Individual.

Securities should be issued in the name(s) of:

----------------------------------            ----------------------------------
(Print or Type Owner's Name)                  (Print or Type Owner's Name)

----------------------------------            ----------------------------------
(Owner's Mailing Address)                     (Owner's Mailing Address)

----------------------------------            ----------------------------------
(City) (State)                                (City) (State)
(Zip)                                         (Zip)

----------------------------------            ----------------------------------
(Telephone)                                   (Telephone)

----------------------------------            ----------------------------------
(Signature of Investor)                       (Signature of Investor)

                                       *

If the Investor is a [ ]  PARTNERSHIP,  [ ] CORPORATION,  [ ] LIMITED  LIABILITY
COMPANY, or [ ] TRUST (check applicable):

----------------------------------            ----------------------------------
(Print Name of Entity as Owner)              (Title)

----------------------------------            ----------------------------------
(Owner Mailing Address)                       (Print Name of Authorized Officer)

                                              by:
----------------------------------            ----------------------------------
(City) (State)                                (SIGNATURE)
(Zip)

SUBSCRIPTION ACCEPTED AND AGREED TO

This ________ Day of __________________ 2004

M.E.R.CORPORATION

By:
   -----------------------------------
   Ronald Mercier, its President

WIRING INSTRUCTIONS:

ABA #022000046
M&T Bank Buffalo NY
A/C 1005242
Account Name:  M.E.R., Inc
Attn:  Joan StapleyExhibit 10.9 Nutra Pharma Corp.

Exhibit 10.9

                              SETTLEMENT AGREEMENT

AGREEMENT made this 28th day of September, 2004, by and between NUTRA PHARMA
CORP., a California corporation ("Nutra Pharma"), and OPUS INTERNATIONAL, LLC.,
a Maryland limited liability company ("Opus"), provides as follows:

In consideration of the mutual promises, covenants, and representations
contained herein, and other good and valuable consideration,

THE PARTIES HERETO AGREE AS FOLLOWS:

1. RECITALS:

This agreement is made and entered into with reference to the following facts
and circumstances:

A. Opus owns 11,692,556 of the outstanding common shares of Nutra Pharma.

B. Nutra Pharma is obligated to Opus in the amount of $1,384,931.26, for funds
advanced to Nutra Pharma by Opus for operating capital, payable on demand.

C. Opus has made demand for payment of the funds owed.

D. Nutra Pharma now holds approximately 10.5 million shares of Infectech, Inc.
("Infectech Shares"), its majority owned subsidiary. Nutra Pharma desires to use
a portion of the Infectech Shares it owns to satisfy its debt to Opus.

2. REPAYMENT AND DISCHARGE OF DEBT

A. Nutra Pharma shall transfer to Opus, in full and fair settlement of the
outstanding debt owed to Opus, certificates representing 6,000,000 shares of
Infectech.

B. Upon the transfer of the Infectech Shares to Opus, any and all outstanding
debt owed to Opus by Nutra Pharma shall be deemed discharged, and Nutra Pharma
shall be released from any and all liability with respect to that debt.

                                       1

3. ADDITIONAL PROVISIONS

Nutra Pharma shall accept the resignations of MITCHELL S. FELDER and DAVID
MCCLELLAND, Sr. from its board of directors.

4. NOTICES

Any notices called for in this agreement shall be effective upon personal
service or upon service by first class mail, postage prepaid, to the parties at
such addresses to be designated by the parties in writing.

5. MISCELLANEOUS PROVISIONS:

This agreement shall be construed in accordance with the laws of the State of
California.

This agreement shall be binding upon and shall inure to the benefit of the
parties hereto, their beneficiaries, heirs, representatives, assigns, and all
other successors in interest.

Each of the parties does hereby promise and agree to execute any and all
documents required to be executed and perform all acts required to be performed
in order to effectuate the terms of this agreement.

This agreement contains all of the agreements and understandings of the parties
hereto with respect to the matters referred to herein, and no prior agreement or
understanding pertaining to any such matters shall be effective for any purpose.

Each of the parties does hereby agree to the use of the particular language of
the provisions of this Agreement, and any question of doubtful interpretation
shall not be resolved by any rule of interpretation against the party who causes
the uncertainty to exist or against the draftsman.

This agreement may not be superseded, amended or added to except by an agreement
in writing, signed by the parties hereto, or their respective
successors-in-interest.

Any waiver of any provision of this agreement shall not be deemed a waiver of
such provision as to any prior or subsequent breach of the same provision or any
other breach of any other provision of this agreement.

If a court of competent jurisdiction holds any provision of this agreement to be
invalid, or unenforceable, said provisions shall be deemed deleted, and neither
such provision, its severance or deletion shall affect the validity of the
remaining provisions of this agreement, which shall, nevertheless, continue in
full force and effect.

The parties may execute this agreement in two or more counterparts, each of
which shall be signed by all of the parties; and each such counterpart shall be
deemed an original instrument as against any party who has signed it.

                                       2

The parties shall use their reasonable best efforts to obtain the consent of all
necessary persons and agencies to the transfer of shares provided for in this
agreement.

The parties agree that they will endeavor to settle any dispute, controversy or
claim arising out of or relating to this Agreement, which they are unable to
settle through direct discussions, by mediation administered by the American
Arbitration Association in accordance with the provisions of the Commercial
Mediation Rules of the American Arbitration Association, and agree that the
arbitrator shall have the power to make injunctive orders, which orders shall be
enforceable in any court of competent jurisdiction, without the right of either
party to appeal. The parties agree to conduct good faith efforts to resolve
their dispute by mediation. The parties agree to submit to mediation conducted
by the American Arbitration Association and to conduct the mediation in a
mutually agreed upon location.

Any dispute, controversy or claim arising out of or relating to this contract,
or the breach thereof, shall be finally settled by arbitration administered by
the American Arbitration Association, in accordance with the commercial rules of
the American Arbitration Association, and judgment on the award rendered by the
arbitrator may be entered in any court having jurisdiction. The number of
arbitrators shall be one, the language of the arbitration shall be in English,
and the place of arbitration shall be Los Angeles, California, United States of
America.

The prevailing party in any mediation, arbitration, or litigation shall be
entitled to recover from the other party reasonable attorney's fees, court
costs, and the administrative costs, fees, and expenses of the American
Arbitration Association, each as applicable, incurred in the same, in addition
to any other relief that may be awarded.

IN WITNESS WHEREOF, the parties have executed this agreement as of the day and
year first above written.

NUTRA PHARMA CORP.

By /s/ Rik J. Deitsch
Rik Deitsch, President

OPUS INTERNATIONAL, LLC.
By /s/ Stephen Hallock
Stephen Hallock, Managing Member

                                       3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00076-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00076-of-00352.parquet"}]]